HOME   |    PDF   |   


Title

Monitoring complications of botulinum toxin in community practice: A pharmacological study

 

Authors

Ambili Remeshı, Taskeen Kaur Sethi², Sree Ram Subba Reddy Gudimetla³, J. Dhanuja Rani4, Debanti Giri5, Rahul Tiwari6,*, Heena Dixit Tiwari7 & Afroz Kalmee Syed8

 

Affiliation

ıDepartment of Pharmacology, Sree Uthradom Thirunal Academy of Medical Sciences, Thiruvananthapuram, Kerala, India; ²Department of Oral and Maxillofacial Surgery, Luxmibai Dental College, Patiala, Punjab, India; ³Department of Oral and Maxillofacial Surgeon, Sree Mithra Dental and MaxFace Specialists, Tanuku andhra Pradesh, India; ⁴Department of Oral & Maxillofacial Pathology, Government Dental College and Research Institute, Ballari, Karnataka, India; 5Department of Oral Medicine and Radiology, Dr. R Ahmed Dental College and Hospital, Kolkata, West Bengal, India; 6Department of Dental Research Cell, Dr. D. Y. Patil Dental College and Hospital, Dr. D. Y. Patil Vidyapeeth (Deemed to be University), Pimpri, Pune 411018, Maharashtra, India; 7Department of Blood Cell, Commissionerate of Health and Family Welfare, Government of Telangana, Hyderabad, India; 8Department of Oral and Maxillofacial Pathology, Scientific Medical Writer, Writing and Publications, Tenali andhra Pradesh, India; *Corresponding author

 

Email

Ambili Remesh - E-mail:  dr.ambiliremesh@gmail.com

Taskeen Kaur Sethi - E-mail: taskeensethi21@gmail.com

Sree Ram Subba Reddy Gudimetla - E-mail: shreeramshree@gmail.com

J Dhanuja Rani - E-mail: dhanujaranij@gmail.com

Debanti Giri - E-mail: drdebantigiri@gmail.com

Rahul Tiwari - E-mail: rahul.tiwari@dpu.edu.in

Heena Dixit Tiwari - E-mail: drheenatiwari@gmail.com

Afroz Kalmee Syed - E-mail: afrozsyed05@gmail.com

 

Article Type

Research Article

 

Date

Received June 1, 2026; Revised June 30, 2026; Accepted June 30, 2026, Published June 30, 2026
 

Abstract

Botulinum toxin is widely used for cosmetic wrinkle reduction, hyperhidrosis, chronic migraine and facial muscle disorders, but concerns persist regarding adverse effects related to injection technique, toxin diffusion and practitioner variability. Therefore, it is of interest to evaluate the complication rates of community-based botulinum toxin therapy and characterize the clinical presentations of its associated adverse effects. A prospective pharmacological observational study was conducted on 120 patients receiving botulinum toxin type A injections. Majority of complications were mild and transient, with injection-site pain and bruising representing the most common local adverse effects. Thus, data shows the botulinum toxin injections performed by trained practitioners have a favorable safety profile in community practice.

 

Keywords

Botulinum toxin, adverse effects, pharmacovigilance, cosmetic procedures, drug safety

 

Citation

Ramesh et al. Bioinformation 22(6): 3718-3722 (2026)

 

Edited by

Vini Mehta  

 

ISSN

0973-2063

 

Publisher

Biomedical Informatics

 

License

This is an Open Access article which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. This is distributed under the terms of the Creative Commons Attribution License.